Premium
Childhood Nail Psoriasis: A Useful Treatment with Tazarotene 0.05%
Author(s) -
DILUVIO LAURA,
CAMPIONE ELENA,
PATERNÒ EVELIN J.,
MORDENTI CRISTINA,
HACHEM MAYA EL,
CHIMENTI SERGIO
Publication year - 2007
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/j.1525-1470.2007.00421.x
Subject(s) - tazarotene , medicine , psoriasis , dermatology , nail (fastener) , nail matrix , clinical trial , nail disease , nail plate , materials science , metallurgy
Nail psoriasis occurs in 7% to 40% of children, with a similar pattern of clinical presentation to that of adults. In 0.6% to 2.3% of the patients nail changes appear as the only sign of the disease, preceding other skin and articular involvement. No pediatric clinical trials are available yet, but considering the successful use of tazarotene for nail dystrophy therapy in adults, we chose this drug to treat a child.